https://doi.org/10.4081/aamr.2024.461

Prevalence and factors associated with adherence to Highly Active Antiretroviral Treatment at the Specialist Hospital Yola, Adamawa State, Nigeria

Vol. 7 (2024)
Submitted: October 9, 2023
Accepted: February 19, 2024
Published: June 21, 2024
PLWHA, HAART, adherence, predictors
Abstract Views: 95
PDF: 53
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Roland I. Stephen
rolandstephen41@yahoo.com
https://orcid.org/0000-0002-8233-7592
Department of Medicine, Modibbo Adama University Teaching Hospital, Yola, Nigeria; Johns Hopkins Fall Institute of Health Policy and Management, Barcelona, Spain.
Joel Rimande
Faculty of Health Sciences, Taraba State University, Jalingo, Nigeria.
Musa AmbiZorto Obadiah
Care Vision Support Initiative, NEMA House, Jos, Nigeria.
Sati Klein Awang
https://orcid.org/0000-0002-9344-0261
Department of Medicine, Modibbo Adama University Teaching Hospital, Yola, Nigeria.
Jacob A Dunga
Department of Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Isaac Bulundi
Adamawa State Specialist Hospital, Yola, Nigeria.
Sonnen Atinge
https://orcid.org/0000-0002-3190-848X
Taraba State Health Services Management Board, Jalingo, Nigeria.

Adherence to Highly Active Antiretroviral Therapy (HAART) medication is an important predictor of a successful treatment and improvement of quality of life among People Living with Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS) (PLWHA). In the seven years before this study, several measures were taken to improve adherence to HAART among PLWHA at the study site, but no work has been published to establish the impact of the measures. We conducted a cross-sectional study among HIV-positive patients attending the antiretroviral clinic of State Specialist Hospital Yola, Adamawa State, Nigeria, in October-December 2019. Adherence was measured using self-report and was defined as taking at least ≥95% of the prescribed doses of Antiretroviral Therapy (ART) in the seven days preceding the survey. A total of 431 PLWHA participated in the study. There was an 88.4% adherence rate, and forgetfulness (62.2%) was the most common reason for missing HAART dosages. Adherence was found to be 92.1% (p=0.017) among those who have been on HAART for ˃2 years, 92.3% (p=0.01) among those not afraid of stigma, and 92.9% (p=0.002) among those who practice Islamic faith. Other factors associated with higher adherence included age less than 34 years, 91.2% (p=0.167), income of ˂₦30,000 per month, 88.6% (p=0.858), and less educated, 90.5% (p=0.852). The study showed adherence prevalence was 88.4%. Forgetfulness was found to be the most common reason for missing HAART dosages. We therefore recommend the introduction of medication adherence reminders into the HIV programs.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Cobucci RNO, Lima PH, Souza PC de, et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Journal of Infection and Public Health 2015;8:1-10. DOI: https://doi.org/10.1016/j.jiph.2014.08.003
Yaya I, Landoh DE, Saka B, et al. Predictors of adherence to antiretroviral therapy among People Living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health 2014;14:1308. DOI: https://doi.org/10.1186/1471-2458-14-1308
Olowookere SA, Fatiregun AA, Akinyemi JO, et al. Prevalence and determinants of nonadherence to Highly Active Antiretroviral Therapy among People Living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries 2008;2:369-72. DOI: https://doi.org/10.3855/jidc.199
Fielden SJ, Rusch MLA, Yip B, et al. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. J Int Assoc Physicians AIDS Care (Chic) 2008;7:238-44. DOI: https://doi.org/10.1177/1545109708323132
Abdulsamad H, Oche OM, Raji MO, Mohammed Y. Prevalence and factors associated with treatment adherence among patients on Highly Active Antiretroviral Therapy (HAART) in Specialist Hospital, Sokoto, Nigeria. International Archives of Medical and Health Research 2019;1:7.
Ekstrand ML, Shet A, Chandy S, et al. Suboptimal adherence associated with virological failure and resistance mutations to first line Highly Active Antiretroviral Therapy (HAART) in Bangalore, India. Int Health 2011;3:27-34. DOI: https://doi.org/10.1016/j.inhe.2010.11.003
Salami AK, Fadeyi A, Ogunmodede JA, Desalu O. Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria. J Int Assoc Physicians AIDS Care (Chic) 2010;9:191-5. DOI: https://doi.org/10.1177/1545109710368722
Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine 2006;3:2039-64. DOI: https://doi.org/10.1371/journal.pmed.0030438
Li L, Lee SJ, Wen Y, et al. Antiretroviral Therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci 2010;12:212-20. DOI: https://doi.org/10.1111/j.1442-2018.2010.00521.x
Vermund SH. Massive benefits of Antiretroviral Therapy in Africa. Journal of Infectious Diseases 2014;209:483-5. DOI: https://doi.org/10.1093/infdis/jit586
Abebe KB, Tegegne AS. Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models. Afr Health Sci 2022;22:443-55. DOI: https://doi.org/10.4314/ahs.v22i1.53
Cadosch D, Bonhoeffer S, Kouyos R. Assessing the impact of adherence to Anti-Retroviral Therapy on treatment failure and resistance evolution in HIV. J R Soc Interface 2012;9:2309-20. DOI: https://doi.org/10.1098/rsif.2012.0127
Yu Y, Luo D, Chen X, et al. Medication adherence to Antiretroviral Therapy among newly treated People Living with HIV. BMC Public Health 2018;18:825. DOI: https://doi.org/10.1186/s12889-018-5731-z
Cochran WG. Sampling techniques. 3rd ed. John Wiley & Sons; New York, USA; 1977.
Hansana V, Sanchaisuriya P, Durham J, et al. Adherence to Antiretroviral Therapy (ART) among People Living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health 2013;13:617. DOI: https://doi.org/10.1186/1471-2458-13-617
Addo MK, Aboagye RG, Tarkang EE. Factors influencing adherence to antiretroviral therapy among HIV/AIDS patients in the Ga West Municipality, Ghana. IJID Reg 2022;3:218-25. DOI: https://doi.org/10.1016/j.ijregi.2022.04.009
Maqutu D, Zewotir T, North D, et al. Determinants of optimal adherence over time to Antiretroviral Therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS Behav 2011;15:1465-74. DOI: https://doi.org/10.1007/s10461-010-9688-x
Chime OH, Ndibuagu EO, Orji CJ. Rates and predictors of adherence and retention for Antiretroviral Therapy among HIV-positive adults in Enugu, Nigeria. Malawi Med J 2019;31:202-11. DOI: https://doi.org/10.4314/mmj.v31i3.7
Hutahaean BSH, Stutterheim SE, Jonas KJ. Barriers and facilitators to HIV treatment adherence in Indonesia: perspectives of People Living with HIV and HIV service providers. Trop Med Infect Dis 2023;8:138. DOI: https://doi.org/10.3390/tropicalmed8030138
Buh A, Deonandan R, Gomes J, et al. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: a cross-sectional study. PLoS One 2023;18:e0283991. DOI: https://doi.org/10.1371/journal.pone.0283991
Aung S, Hardy N, Chrysanthopoulou SA, et al. Stigma determines antiretroviral adherence in adults with HIV in Myanmar. J Acquir Immune Defic Syndr 2022;89:19-26. DOI: https://doi.org/10.1097/QAI.0000000000002813
Morowatisharifabad MA, Movahed E, Farokhzadian J, et al. antiretroviral therapy adherence based on information, motivation, and behavioral skills model and its association with depression among HIV-positive patients: health promotion strategy towards the 909090 target. J Educ Health Promot 2019;8:192. DOI: https://doi.org/10.4103/jehp.jehp_42_19
Tsega B, Srikanth BA, Shewamene Z. Determinants of non-adherence to Antiretroviral Therapy in adult hospitalized patients, Northwest Ethiopia. Patient Prefer Adherence 2015;9:373-80. DOI: https://doi.org/10.2147/PPA.S75876
Crim SM, Tie Y, Beer L, et al. Barriers to Antiretroviral Therapy adherence among HIV-positive Hispanic and Latino men who have sex with men - United States, 2015-2019. MMWR Morb Mortal Wkly Rep 2020;69:1437-42. DOI: https://doi.org/10.15585/mmwr.mm6940a1
Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of Antiretroviral Therapy in a tertiary hospital in Nigeria. Niger J Clin Pract 2013;16:302-8. DOI: https://doi.org/10.4103/1119-3077.113451
Ibeneme SC, Ndukwu SC, Myezwa H, et al. Effectiveness of mobile text reminder in improving adherence to medication, physical exercise, and quality of life in patients living with HIV: a systematic review. BMC Infectious Diseases 2021;21:859. DOI: https://doi.org/10.1186/s12879-021-06563-0

How to Cite

Stephen, R. I., Rimande , J., Obadiah, M. A., Awang, S. K., Dunga, J. A., Bulundi, I., & Atinge, S. (2024). Prevalence and factors associated with adherence to Highly Active Antiretroviral Treatment at the Specialist Hospital Yola, Adamawa State, Nigeria. Annals of African Medical Research, 7(1). https://doi.org/10.4081/aamr.2024.461
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.